OncoTarget®500 genomic profiling identifies tumor-based somatic mutations with high accuracy and sensitivity – single nucleotide variants (SNVs), small insertions and deletions, amplifications, translocations, microsatellite instability (MSI) and tumor mutation burden (TMB). OncoTarget® 500 is designed to be used by qualified healthcare professionals in accordance with professional guidelines in oncology for previously diagnosed cancer patients.